http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7507739-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
filingDate | 2004-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2009-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2f36fd2d079768f9a35144949e4f614 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb54c80355b2505f72019786ff33d94c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00135dfa09767fd243df1204cda7db46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49c92784f96db38789a05d2a9f5d531d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_102ac35931c3ba11e3e176d28f3d0bde |
publicationDate | 2009-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-7507739-B2 |
titleOfInvention | 6-[(substituted)phenyl]triazolopyrimidines as anticancer agents |
abstract | This invention relates to certain 6-[(substituted)phenyl]triazolopyrimidine compounds or pharmaceutically acceptable salts thereof, and compositions containing said compounds or pharmaceutically acceptable salts thereof, wherein said compounds are anti-cancer agents useful for the treatment of cancer in mammals. This invention further relates to a method of treating or inhibiting the growth of cancerous tumor cells and associated diseases in a mammal and further provides a method for the treatment or prevention of cancerous tumors that express multiple drug resistance (MDR) or are resistant because of MDR, in a mammal in need thereof which method comprises administering to said mammal an effective amount of said compounds or pharmaceutically acceptable salts thereof. The present invention relates to a method of treating or inhibiting the growth of cancerous tumor cells and associated diseases in a mammal in need thereof by promotion of microtubule polymerization which comprises administering to said mammal an effective amount of said compounds and pharmaceutically acceptable salts thereof. |
priorityDate | 2003-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 989.